“Evidence Level for Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Respectively Sodium Glucose Co-Transporter-2 Inhibitors for Mitochondrial Diabetes Is Low”. Innovative Journal of Medical and Health Sciences 10, no. 06 (June 17, 2020): 959–960. Accessed October 23, 2026. http://www.innovativejournal.in/index.php/ijmhs/article/view/2988.